Duan X - Search Results

1

[Study on clinicopathological classification and clinical and pathological characteristics in breast cancer].

Hu H, Liu Q, Xu L, Ye J, Zhao J, Duan X, Liu Y. Hu H, et al. Among authors: duan x. Zhonghua Wai Ke Za Zhi. 2014 Feb;52(2):113-6. Zhonghua Wai Ke Za Zhi. 2014. PMID: 24809519 Chinese.

2

Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.

Zhang C, Duan X, Xu L, Ye J, Zhao J, Liu Y. Zhang C, et al. Among authors: duan x. Breast Cancer Res Treat. 2012 Dec;136(3):739-48. doi: 10.1007/s10549-012-2316-x. Epub 2012 Nov 2. Breast Cancer Res Treat. 2012. PMID: 23117856

3

Multicenter prospective study of magnetic resonance imaging prior to breast-conserving surgery for breast cancer.

Liu Q, Liu Y, Xu L, Duan X, Li T, Qin N, Kang H, Jiang H, Yang D, Qu X, Jiang Z, Yu C. Liu Q, et al. Among authors: duan x. Chin Med J (Engl). 2014;127(13):2401-6. Chin Med J (Engl). 2014. PMID: 24985573

4

[Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study].

Xin L, Liu Q, Xu L, Jiang Z, Jiang H, Qin N, Li T, Duan X, Liu Y. Xin L, et al. Among authors: duan x. Zhonghua Yi Xue Za Zhi. 2014 Jul 8;94(26):2018-21. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25312661 Chinese.

5

[Analysis of detecting value of ultrasound and the clinic-pathological features of axillary metastasis in breast cancer].

Xin L, Chen L, Zhang H, Liu Q, Xu L, Wang B, Li T, Duan X, Liu Y. Xin L, et al. Among authors: duan x. Zhonghua Wai Ke Za Zhi. 2014 Dec;52(12):924-8. Zhonghua Wai Ke Za Zhi. 2014. PMID: 25622584 Chinese.

6

[Re-evaluation of HER2 status in 1 501 invasive breast cancers according to the 2013 American Society of Clinical Oncology/College of American Pathology guidelines].

Zhang H, Zhang S, Wang Y, Li D, Xu L, Liu Q, Duan X, Liu Y, Li T. Zhang H, et al. Among authors: duan x. Zhonghua Bing Li Xue Za Zhi. 2015 Jan;44(1):42-7. Zhonghua Bing Li Xue Za Zhi. 2015. PMID: 25765030 Chinese.

7

[Clinicopathological features of Luminal B-like breast cancer].

Hu H, Liu Q, Xu L, Ye J, Duan X, Liu Y. Hu H, et al. Among authors: duan x. Zhonghua Yi Xue Za Zhi. 2015 Jan 27;95(4):248-51. Zhonghua Yi Xue Za Zhi. 2015. PMID: 25877237 Chinese.

8

Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy.

Liu S, Duan X, Xu L, Xin L, Cheng Y, Liu Q, Ye J, Zhang S, Zhang H, Zhu S, Li T, Liu Y. Liu S, et al. Among authors: duan x. Breast Cancer Res Treat. 2015 Nov;154(2):239-49. doi: 10.1007/s10549-015-3617-7. Epub 2015 Oct 26. Breast Cancer Res Treat. 2015. PMID: 26498019

9

Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy.

Liu S, Duan X, Xu L, Ye J, Cheng Y, Liu Q, Zhang H, Zhang S, Zhu S, Li T, Liu Y. Liu S, et al. Among authors: duan x. Tumour Biol. 2016 Apr;37(4):4873-81. doi: 10.1007/s13277-015-4325-y. Epub 2015 Nov 2. Tumour Biol. 2016. PMID: 26526577

10

[Neoadjuvant treatment in human epidermal growth factor receptor 2-positive breast cancer].

Liu Y, Liu S, Zhang H, Xu L, Li T, Duan X. Liu Y, et al. Among authors: duan x. Zhonghua Wai Ke Za Zhi. 2015 Dec 1;53(12):901-4. Zhonghua Wai Ke Za Zhi. 2015. PMID: 26850663 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,986 results

Search Page

Filters